Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals
- 1 May 1999
- journal article
- Published by Wiley in Health Economics
- Vol. 8 (3) , 269-274
- https://doi.org/10.1002/(sici)1099-1050(199905)8:3<269::aid-hec425>3.0.co;2-d
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Bayesian BiostatisticsPublished by Taylor & Francis ,2018
- The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologiesJournal of Health Economics, 1999
- The Cost-Benefit of a Randomized Trial to a Health Care OrganizationControlled Clinical Trials, 1998
- Sensitivity Analysis and the Expected Value of Perfect InformationMedical Decision Making, 1998
- The Value of Improved National Exposure Information for Perchloroethylene (Perc): A Case Study for Dry CleanersRisk Analysis, 1997
- An economic approach to clinical trial design and research priority-settingHealth Economics, 1996
- The FDA And Regulation Of Cost-Effectiveness ClaimsHealth Affairs, 1996